Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
PSCAO43653Prostate stem cell antigenCancer-related genesPredicted intracellular proteinsPredicted membrane proteinsNon-small-cell lung cancerPancreatic cancerProstate cancerClinical-translation mediationMetabolism mediationReceptor-signaling mediation20.50
PTAFRP25105Platelet-activating factor receptor (PAF-R) (PAFr)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Allergic/hypersensitivity disorderAsthmaCardiac arrhythmiaAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
RAPSNQ1370243 kDa receptor-associated protein of the synapse (RAPsyn) (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205)Disease related genesHuman disease related genesPredicted intracellular proteinsAdhesion and uptake mediation20.50
RHOAP61586Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)Cancer-related genesDisease related genesEnzymesSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
S13A5Q86YT5Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5)Disease related genesHuman disease related genesMetabolic proteins11Fusion and delivery mediation20.50
S19A3Q9BZV2Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3)Disease related genesHuman disease related genesMetabolic proteins12Fusion and delivery mediationMetabolism mediation20.50
S67A1Q96BI1Solute carrier family 67 member A1 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein) (Efflux transporter-like protein) (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Organic cation transporter-like protein 2) (ORCTL-2) (Solute carrier family 22 member 1-like) (Solute carrier family 22 member 18) (Tumor-suppressing STF cDNA 5 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein) (p45-Beckwith-Wiedemann region 1 A) (p45-BWR1A)Disease related genesHuman disease related genesMetabolic proteins10Clinical-translation mediationFusion and delivery mediation20.50
SI1L3O60292Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3)Disease related genesHuman disease related genesPredicted intracellular proteinsFusion and delivery mediationReceptor-signaling mediation20.50
SLIK6Q9H5Y7SLIT and NTRK-like protein 6Disease related genesHuman disease related genesPredicted membrane proteins1Bladder cancerUreteral cancerClinical-translation mediation20.50
SMOC1Q9H4F8SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1)Disease related genesHuman disease related genesPredicted secreted proteinsOther mediation20.50
SSR3P32745Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Alzheimer diseaseCushing syndromeStomach cancerClinical-translation mediationReceptor-signaling mediation20.50
STYK1Q6J9G0Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1)EnzymesPredicted intracellular proteinsPredicted membrane proteins1Other mediation20.50
TLR4O00206Toll-like receptor 4 (hToll) (CD antigen CD284)CD markersFDA approved drug targetsHuman disease related genes1Allergic/hypersensitivity disorderDiabetes mellitusHepatitis virus infectionClinical-translation mediationFusion and delivery mediationImmune mediation20.50
TMPS2O15393Transmembrane protease serine 2 (EC 3.4.21.122) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]Cancer-related genesEnzymesPredicted intracellular proteins1COVID-19Middle East Respiratory SyndromeSevere acute respiratory syndromeClinical-translation mediationMetabolism mediation20.50
UPARQ03405Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87)Cancer-related genesCD markersFDA approved drug targetsAcquired hypomelanotic disorderAtopic eczemaMyeloproliferative neoplasmAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
ABCC9O60706ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2)Disease related genesFDA approved drug targetsHuman disease related genes15Acute diabete complicationAngina pectorisMultiple sclerosisClinical-translation mediationFusion and delivery mediationImmune mediation10.50
ABCG2Q9UNQ0Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)Cancer-related genesCD markersEnzymes6Irritable bowel syndromeRheumatoid arthritisClinical-translation mediationFusion and delivery mediationMetabolism mediation10.50
ACKR3P25106Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1)Cancer-related genesDisease related genesG-protein coupled receptors7AsthmaSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
ACTN1P12814Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)Disease related genesFDA approved drug targetsHuman disease related genesAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
ADAP00813Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)Disease related genesEnzymesFDA approved drug targetsAdaptive immunity immunodeficiencyChronic painImmunodeficiencyAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
ADA33Q9BZ11Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-)Disease related genesHuman disease related genesPredicted membrane proteins1Receptor-signaling mediation10.50
ADCY5O95622Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)Disease related genesEnzymesHuman disease related genes12Clinical-translation mediationFusion and delivery mediationMetabolism mediation10.50
AGRG2Q8IZP9Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]Disease related genesG-protein coupled receptorsHuman disease related genes7Fusion and delivery mediationReceptor-signaling mediation10.50
AKA12Q02952A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen)Cancer-related genesPlasma proteinsPredicted intracellular proteinsAdhesion and uptake mediationFusion and delivery mediationImmune mediation10.50
ALKQ9UM73ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)Cancer-related genesCD markersDisease related genes1Adrenal cancerBreast cancerColorectal cancerClinical-translation mediationReceptor-signaling mediation10.50

226-250 of 792 proteins

Page